Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Transvaginal Radiofrequency Ablation With Morpheus Device for Treatment of Overactive Bladder.

NCT06458556 is registered in ClinicalTrials.gov with InMode MD Ltd. as lead sponsor.

NCT NCT06458556
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06458556 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Transvaginal Radiofrequency Ablation With Morpheus Device for Treatment of Overactive Bladder.
Lead sponsor
InMode MD Ltd.
Phase
Not applicable
Overall status
Completed
Start date
June 19, 2023
Completion date
May 30, 2024
Enrollment
17 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

overactive bladder